Dividend Stocks
Search documents
The Richest 0.1% Are Buying These 3 Dividend Stocks Right Now
Yahoo Finance· 2025-10-30 15:41
Paul Morigi / Getty Images When ultra-rich investors start coalescing into the same names or put an unusually large amount of money into a single stock, that should raise more interest. That's exactly what we're seeing with UnitedHealth (NYSE:UNH), Visa (NYSE:V), and Danaher (NYSE:DHR). These investors have far more resources than the average Joe. Perhaps, they know something about these investments that you don't. The current environment is pivotal, and certain rich investors are rotating into dividend ...
EHI: Solid Dividend Coverage But Limited Growth Potential (NYSE:EHI)
Seeking Alpha· 2025-10-30 02:45
Core Insights - As market indexes approach all-time highs, investors are seeking alternatives to traditional equities to mitigate volatility and uncertainty [1] Investment Strategy - The article discusses a hybrid investment strategy that combines classic dividend growth stocks with Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds like the S&P [1]
EHI: Solid Dividend Coverage But Limited Growth Potential
Seeking Alpha· 2025-10-30 02:45
Core Insights - As market indexes approach all-time highs, investors are seeking alternatives to traditional equities to mitigate volatility and uncertainty [1] Investment Strategy - The article emphasizes a hybrid investment strategy that combines classic dividend growth stocks with Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds [1]
Oppenheimer Lowers Price Target on Church & Dwight (CHD) to $100 Amid Sector Challenges
Yahoo Finance· 2025-10-30 02:26
Core Insights - Church & Dwight Co., Inc. (NYSE:CHD) is recognized as one of the 13 most undervalued dividend stocks according to Wall Street analysts [1] - Oppenheimer has lowered its price target for Church & Dwight from $115 to $100 while maintaining an Outperform rating, citing sector challenges [2][3] Company Performance - Church & Dwight announced a quarterly dividend of $0.295 per share, consistent with previous payouts, and has a strong dividend history with 29 consecutive years of increases and 124 years of regular dividends [4] - As of October 29, the stock has a dividend yield of 1.44% [4] Sector Challenges - Oppenheimer highlights several challenges in the consumer packaged goods (CPG) sector, including limited pricing power, GLP-1 risks affecting food brands, a focus on private-label products by major retailers, tariff concerns, and changing consumer preferences [3]
ETO: Discounted Buy-And-Hold Global Income Fund
Seeking Alpha· 2025-10-29 03:30
Core Insights - The article emphasizes the importance of a hybrid investment strategy that combines classic dividend growth stocks with Business Development Companies, REITs, and Closed End Funds to enhance investment income while achieving total returns comparable to traditional index funds [1]. Investment Strategy - The company advocates for a balanced approach to investing, focusing on high-quality dividend stocks that provide long-term growth potential and reliable income [1]. - The strategy aims to create a robust investment portfolio that not only generates income but also captures total returns on par with the S&P 500 [1].
Prediction: These Dividend Stocks Could Outperform Growth Stocks in the Next Decade
Yahoo Finance· 2025-10-26 15:21
Core Insights - Companies prioritizing dividends may have less capital for reinvestment, potentially leading to lower returns, although some dividend stocks can outperform growth stocks [1] Group 1: Dividend Payers - AbbVie is a notable dividend payer, having raised its dividends for 53 consecutive years, and is part of the Dividend Kings group [4] - AbbVie offers a forward yield of 2.8%, significantly higher than the S&P 500's average of 1.2%, with a cash payout ratio of 61.8% [5] - The company has a diversified revenue stream from various therapeutic areas, which helps maintain demand for its products regardless of economic conditions [6] Group 2: Growth Prospects - AbbVie is expected to see revenue and earnings growth driven by its immunology drugs, Skyrizi and Rinvoq, which are expected to continue strong sales growth into the next decade [7] - The company has successfully navigated a major patent cliff and secured Rinvoq's patent exclusivity until 2037 in the U.S. [7][9] - AbbVie is anticipated to launch new medicines, further enhancing its top-line growth without facing significant patent losses through the end of the decade [9]
3 Dividend Stocks Every Boomer Should Own for Reliable Income
247Wallst· 2025-10-26 14:26
Core Insights - The article highlights that Baby Boomers are currently aged between 60 and 79 years old [1] Group 1 - The demographic of Baby Boomers is significant for various industries, particularly in healthcare and retirement services, as this age group is entering a phase of increased demand for these services [1]
BTX: Cannot Support Dividend Payouts (NYSE:BTX)
Seeking Alpha· 2025-10-24 07:22
Since the time of my last coverage, BlackRock Technology and Private Equity Term Trust (NYSE: BTX ) has made some shifts to its portfolio and name. The fund's ticker changed from BIGZ, and the name nowFinancial analyst by day and a seasoned investor by passion, I've been involved in the world of investing for over 15 years and honed my skills in analyzing lucrative opportunities within the market.I specialize in uncovering high quality dividend stocks and other assets that offer potential for long term-grow ...
Hormel Foods Stock: Shares Haven't Been This Cheap In A Decade (NYSE:HRL)
Seeking Alpha· 2025-10-24 03:00
Core Viewpoint - Hormel Foods (NYSE: HRL) has experienced poor stock performance due to lackluster results and general weakness in consumer staples, but analysts believe these issues are temporary and overlook the company's strengths [1]. Company Performance - Hormel Foods shares have been negatively impacted by recent financial results and broader market trends affecting consumer staples [1]. Analyst Perspective - An analyst suggests that the current challenges faced by Hormel Foods are not indicative of long-term issues, implying potential for recovery and growth in the future [1].
The Nasdaq Composite Rallies. Risk Is Back On—For Now.
Barrons· 2025-10-23 16:45
Group 1 - The Nasdaq Composite increased by 0.8%, indicating a return to riskier stocks after a previous decline [1] - The S&P 500 rose by 0.5%, while the Dow Jones gained 83 points, or 0.2% [1] - Exchange-traded funds focused on momentum, higher volatility stocks, and small-caps were among the top performers, contrasting with low volatility and dividend stocks that struggled [2]